| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 41.52B | 37.90B | 34.86B | 31.35B | 26.49B |
| Gross Profit | 32.26B | 29.25B | 26.32B | 22.99B | 19.47B |
| EBITDA | 13.15B | 11.14B | 9.22B | 5.64B | 3.85B |
| Net Income | 7.46B | 6.20B | 4.14B | 208.00M | 1.44B |
Balance Sheet | |||||
| Total Assets | 112.31B | 102.93B | 99.82B | 98.85B | 95.21B |
| Cash, Cash Equivalents and Short-Term Investments | 9.56B | 14.03B | 14.19B | 12.51B | 10.54B |
| Total Debt | 17.18B | 11.39B | 12.59B | 14.09B | 13.98B |
| Total Liabilities | 53.16B | 41.76B | 40.18B | 40.49B | 37.08B |
| Stockholders Equity | 59.14B | 61.17B | 59.65B | 58.36B | 58.13B |
Cash Flow | |||||
| Free Cash Flow | 14.40B | 12.43B | 9.50B | 6.31B | 5.28B |
| Operating Cash Flow | 15.00B | 13.09B | 10.23B | 7.11B | 6.00B |
| Investing Cash Flow | -8.59B | -3.16B | -1.33B | -1.99B | -14.54B |
| Financing Cash Flow | -8.08B | -9.43B | -7.48B | -3.56B | 7.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $116.05B | 90.88 | 15.42% | ― | 21.05% | 28.67% | |
71 Outperform | $180.15B | 27.05 | 12.37% | 0.63% | 8.41% | 22.92% | |
70 Outperform | $13.82B | 458.50 | 2.30% | ― | 19.21% | 75.32% | |
69 Neutral | $202.95B | 34.25 | 16.82% | 1.07% | 11.85% | 167.23% | |
69 Neutral | $35.22B | 66.22 | 7.97% | ― | 13.35% | -60.76% | |
67 Neutral | $3.83B | 63.93 | 9.88% | ― | 28.62% | 186.67% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |